nglml, the cut off point for smoking "deceivers", took part. Results -Fewer than one third of never smokers reported no recent exposure to environmental tobacco smoke and the same proportion had no detectable cotinine. Women had lower cotinine values than men but reported more exposure to smoke. The correlation between the measures of exposure was poor. Self reported exposure showed strong, statistically significant, dose response relationships with respiratory symptoms and with the coronary disease markers. These relationships were weak or absent for serum cotinine, except for diagnosed coronary heart disease. Here the dose response gradient was as strong as that for selfreport, with an odds ratio of 2-7 (95% CI 1-3, 5.6) for the highest v the lowest exposure group, adjusted for age, housing tenure, total cholesterol, and blood pressure, and not explained by fibrinogen. Conclusions -The validity of different measures oftobacco smoke exposure needs further investigation. The gradient ofdiagnosed coronary heart disease with both self reported exposure and serum cotinine was, however, surprisingly strong, statistically significant, and unexplained by other factors. These findings reinforce current policies to limit passive tobacco smoke exposure. Because of the low dose levels involved, investigation of the long term effects of passive exposure to tobacco smoke in non-smokers stretches epidemiological studies to their limits. If the excess risk over non-exposure is small, it may be explained by confounding factors, or the inclusion of furtive smokers,' if it is large, it may lack a plausible biological mechanism. Opinion is divided on whether evidence on passive smoking in relation to coronary heart disease (CHD) is unconvincing,2 sufficiently suggestive that it cannot be ignored,3 or proving that thousands of deaths a year are caused by it.' The issue is of considerable importance to the public health.
Most studies of passive smoking have been done without biochemical validation to grade the exposure and exclude smoking deceivers. In a large cross sectional population survey, the Scottish heart health study (SHHS), we asked non-smokers about recent exposure to tobacco smoke and also measured their serum cotinine. 7 We related these to questionnaire and electrocardiographic evidence of disease.
Subjects and methods

SURVEY METHOD
Men and women aged 40-59 years were recruited by random sampling from general practitioner lists between 1984 and 1986.8 Each was sent a "personal health record" to complete and a clinic appointment. The former included the standard Rose angina and possible infarction questionnaire; the Medical Research Council cough and phlegm questionnaire; questions on prior medical diagnoses, on current and former consumption of cigarette, pipe, or cigar tobacco; and the question, "Have you been exposed to tobacco smoke from someone else in the last three days?" with possible answers of: "1 -yes, a lot; 2 -yes, some; 3 -yes, a little; 4 -none at all".
Relevant clinic procedures included checking the questionnaire, a 12 lead electrocardiogram, and venepuncture. Blood analyses included serum cholesterol, serum cotinine, assayed by No is the observed number in each subgroup, and O/E the ratio between the observed number and that expected in the subgroup if there were no association between self report and serum cotinine.
All CHD was the preceding two categories combined. categories are combined, the odds ratio in group IV is lower than that in the comparable "a lot" group and it does not reach statistical significance after adjustment, although this is reached if groups III and IV are combined. In diagnosed CHD the gradient is stronger than for self report. The odds ratio for group IV is significantly high, and this is also true for groups III and IV combined.
Plasma fibrinogen findings do not explain the raised odds ratios for coronary heart disease.
Any possible gradient by passive smoking group is tiny (table 3). The correlation coefficient between plasma fibrinogen and serum cotinine in never smokers before adjustment was 0-038. After adjustment for the factors listed it was 0-033, and insignificant. By contrast with the gradient shown, the mean fibrinogen in active tobacco smokers in the SHHS was 2-46 g/l, and in ex-smokers 2-25 gil, after adjustment for the same factors.
Discussion TOBACCO SMOKE EXPOSURE IN THE GENERAL POPULATION
Only one third of never smokers had no recent exposure to tobacco smoke by either method of assessment, or one sixth if they are combined (table 2) . This implies that only 5-10% of the whole SHHS population, typical of Scotland in 1984-6, had neither smoked in the past or been passively exposed in the last few days. This estimate may be too low if nicotine in food affects the serum cotinine,15 16 or too high, as assay methods are not improved and more sensitive" " than the one used for the SHHS.9 DISAGREEMENT BETWEEN SELF REPORTED DEGREE OF EXPOSURE AND SERUM COTININE MEASUREMENTS Their poor correlation with each other and disparate association with disease undermine the validity of the two measures of passive smoking. We doubt that either measure is more ephemeral as exposure is usually chronic, and responses and serum cotinine concentrations did not fluctuate much by day of the week. Self report concerned exposure during three days, and the half life of serum cotinine in nonsmokers can be as much as 40 hours. '8 It is claimed that cotinine is a poor measure of passive smoking'5 because of individual variation in nicotine metabolism'9 and traces of nicotine in foodstuffs.'6 The latter claims do not seem to have been substantiated in human data; our analyses from the SHHS refute the claim that heavy tea consumption would interfere with the relationship between passive smoking and serum cotinine." The four cotinine groups cover a huge range of readings so a degree of variation in metabolism and imprecision in the cotinine assay9 should not invalidate the broad ranking. Amalgamation into two rather than four groups does not change the study findings.
Self report could be biased. Our cigarette smoking men and women ran similar serum cotinine concentrations for the same cigarette consumption,7 so the lower cotinine in women shown here for higher self reported exposure suggests a possible bias in reporting of the latter. Those study participants with hyperreactive bronchial mucosa might react to tobacco smoke by exaggerating exposure (questionnaire positive) and avoiding it (cotinine negative). Twenty four of 188 of those complaining of cough or phlegm were on treatment for asthma with bronchodilators or corticosteroids or both. Participants with symptoms of disease might exaggerate exposure because they had heard of an association. This is plausible in the middle 1 980s for respiratory disease, but less so for diagnosed coronary heart disease and implausible for its undiagnosed manifestations. Table 3 shows paradoxically that it is the undiagnosed group which show a greater odds ratio for self report than for cotinine, whereas the diagnosed group shows the opposite. We cannot therefore explain the discrepancies between self report and serum cotinine, and consider that more needs to be done on the validation of these measures as passive smoking becomes of increasing public health and medico-legal interest. If self reported exposure is unreliable it still suggests that those with early markers of disease tolerate smoke exposure badly.
PASSIVE SMOKING AND CORONARY HEART DISEASE Self reported exposure shows a significant gradient for all categories of coronary heart disease, considered separately or together (table 3) . If exposure is assessed using cotinine only diagnosed CHD shows a significantly high odds ratio in the highest exposure group after adjustment whereas all CHD (to which it contributes) shows a significant excess only if groups III and IV are combined. Undiagnosed CHD shows slight evidence of a gradient but questionnaire angina shows none at all. A possible explanation for the greater gradient with diagnosed CHD is its greater specificity. The undiagnosed category includes more mild and asymptomatic cases, but it is diluted with false positives.
The odds ratios of interest are those for diagnosed CHD and all CHD. After adjustment, the odds ratios for the top group are 2A4 and 1-6 (see table 3) for self report, and 2 7 and 1 2 for cotinine. Odds ratios in published studies of heart disease and passive smoking show considerable variation, ranging from 0-97 to 3 0, but some of these lack precision because of small numbers. 
